What Happened
A registered nurse in the cardiac catheterization lab of a Miami hospital was sentenced to more than two years in federal prison for tampering with medical-grade fentanyl meant to treat patients during cardiac catheterization and stent placement procedures.
While on duty from July 10 to August 18, 2023, the nurse used a syringe to extract medical-grade fentanyl and midazolam from vials for his personal use, then replaced the contents with saline solution, knowing the vials would be dispensed to hospital patients for pain relief during procedures. He went further to cover the theft: he retrieved empty and discarded vials from the biohazard waste disposal bin — which contained other contaminated medical waste — filled them with saline, and used them to replace the vials he had stolen.
His conduct exposed patients not only to unnecessary pain from receiving saline instead of pain medication, but also to the risk of contracting Hepatitis C and other bloodborne diseases from contaminated waste material. The hospital fired him, notified affected patients, and offered free blood testing; no acute infections were discovered. In a separate state prosecution, he also admitted to stealing fentanyl from another Miami-area hospital in March 2023. He pleaded guilty to tampering with consumer products on December 13, 2024, and was sentenced on March 18, 2025.
What Went Wrong
A cath lab nurse was able to divert fentanyl using biohazard waste to disguise the theft, across two different hospitals. Key failure points:
- Biohazard waste was accessible and reusable as a tampering resource. The nurse was able to retrieve discarded, contaminated vials from a waste bin and reintroduce them into the medication supply chain, indicating waste disposal was not secured against retrieval.
- Saline substitution went undetected at the point of care. Patients undergoing cardiac catheterization received saline instead of ordered pain medication without clinical staff noticing before or during the procedure.
- Prior diversion at another hospital was not caught in time. The nurse had already stolen fentanyl from a different Miami-area hospital before this conduct, suggesting no shared reporting mechanism flagged him across employers.
- High-risk infection exposure went undetected until after the fact. Using biohazard-bin vials created a contamination pathway that was not identified until after the tampering was already discovered through other means.
How It Could Have Been Prevented
- Secure biohazard and sharps waste disposal against retrieval, and treat any recovered vial found outside the waste stream as a serious incident.
- Perform routine weight or volume verification on high-risk controlled substance vials used in procedural areas like cath labs, before and after use.
- Check for effect — confirm patients received the expected level of pain relief or sedation during procedures, and investigate unexplained reports of inadequate pain control.
- Cross-reference new hires' employment history for prior diversion investigations at other facilities, including through licensing board and staffing agency disclosures.
- Establish a rapid, standardized bloodborne pathogen exposure notification protocol so any diversion incident triggers immediate patient risk assessment.
Related Guidance
- Diversion prevention checklist — Self-assessment for procedural areas including cath labs.
- Patient Notification After Drug Diversion — When and how to notify potentially exposed patients, including bloodborne pathogen risk.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion by clinical staff.
- Investigation Playbook — How to run an internal diversion investigation when staff or product integrity is questioned.
- Waste Documentation Policies — Witnessed waste and documentation requirements for controlled substances that are not fully administered.